Register Now - Every Drop Matters: Reducing Product Loss in Sterile Filtration
|Articles|December 11, 2015

GRAM Expands Disposable Capabilities

Grand River Aseptic Manufacturing expands disposable technology capabilities at aseptic facility.

Grand River Aseptic Manufacturing (GRAM) announced on Dec. 9, 2015, that the company has expanded disposable technology capabilities at its FDA-approved manufacturing facility in Grand Rapids, MI.

According to a company press release, the disposable technology will offer customers cost and time savings, improved safety and quality standards, reduced process development timelines, and greater flexibility in process design process, and reduced client cross-contamination risks.

By utilizing disposable technology, the company can benefit from efficiency gains by reducing processing, cleaning, and prep time. Manufacturing downtime is also reduced due to the elimination of cleaning validation activities, the company reports.

Source: Grand River Aseptic Manufacturing

 

 


Related to this article

The BioPharm Brief: Long-Term Survival Data for a PD-L1/4-1BB Bispecific, Celldex Exits Atopic Dermatitis, and a Fc-Fusion GLP-1 Goes Global
Leads Biolabs details survival data and 2027 ADC combination plans for its PD-L1/4-1BB bispecific opamtistomig, Celldex Therapeutics ends its atopic dermatitis program for anti-KIT antibody barzolvolimab after a phase 2 miss, and Innogen licenses its Fc-fusion GLP-1 receptor agonist efsubaglutide alfa to Arcera Life Sciences for international markets.